Form 4: Ginkgo Bioworks Executive Steven Coen Reports Stock Transactions

Steven P. Coen, Chief Accounting Officer of Ginkgo Bioworks Holdings, Inc., reports transactions involving Class A Common Stock and Restricted Stock Units.

Summary

• On March 3, 2025, Steven P. Coen, Chief Accounting Officer of Ginkgo Bioworks Holdings, Inc., exercised restricted stock units (RSUs) to acquire 587 and 156 shares of Class A Common Stock.
• Following these transactions, Coen directly owns 8,251 and 8,407 shares of Class A Common Stock respectively.
• On March 4, 2025, Coen sold 395 shares of Class A Common Stock at a price of $7.725 per share to cover tax withholding obligations.
• After the sale, Coen directly owns 8,012 shares of Class A Common Stock.
• Coen also holds 15,275 and 5,627 Restricted Stock Units.
• The RSUs vest in monthly installments following an initial vesting date of May 1, 2024.

Sentiment

Score: 5

Explanation: This is a neutral report of stock transactions by an insider. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the trading activities of company executives.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership by a company executive.
• The sale of shares to cover tax obligations is a standard practice and doesn't necessarily indicate a change in the executive's confidence in the company.

Key Dates